Adherex Technologies Inc. (FENC) vs Rezolute, Inc. (RZLT)

Adherex Technologies Inc. and Rezolute, Inc. are both Biotechnology companies. Adherex Technologies Inc. and Rezolute, Inc. are of similar size ($379.4M and $372.4M). Rezolute, Inc. has the higher net margin (0.00% vs −5.49%) and the higher return on invested capital (0.00% vs −58.9%). Across the 13 metrics below, Rezolute, Inc. leads on 8 and Adherex Technologies Inc. on 5.

Valuation

Metric FENC RZLT Biotechnology median
P/E n/m n/m 7.88
P/S 6.19 n/m 11.47
P/B 8.64 3.47 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 5.80 n/m 10.73
Earnings yield (1.17%) (21.03%) (28.84%)
Free cash flow yield (0.56%) (18.30%) (23.03%)

Profitability

Metric FENC RZLT Biotechnology median
Gross margin 93.73% 0.00% 65.16%
Operating margin (1.90%) 0.00% 0.00%
Net margin (5.49%) 0.00% 0.00%
Free cash flow margin (3.44%) 0.00% 0.00%
Return on equity (18.58%) (81.73%) (57.72%)
Return on assets (5.39%) (74.01%) (49.22%)
Return on invested capital (58.89%) 0.00% 0.00%

Growth

Metric FENC RZLT Biotechnology median
Revenue growth (TTM) 77.83% — 5.64%
EPS growth (last fiscal year) (2,087.50%) 26.32% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FENC RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.85 15.84 4.73
Net debt to EBITDA 6.02 2.04 0.96

Dividend

Metric FENC RZLT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FENC RZLT Biotechnology median
Market cap 372.41m 379.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack